4//SEC Filing
Halladay Benjamin 4
Accession 0001628280-25-013812
CIK 0001434868other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 4:03 PM ET
Size
18.0 KB
Accession
0001628280-25-013812
Insider Transaction Report
Form 4
Halladay Benjamin
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-03-18$1.48/sh−3,535$5,242→ 481,710 total
Footnotes (1)
- [F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.
Documents
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeother
Related Parties
1- filerCIK 0001953943
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 4:03 PM ET
- Size
- 18.0 KB